Ozempic Linked to Increased Risk of Rare Eye Disease: New Studies Reveal

Recent studies from researchers at the University of Southern Denmark (Syddansk Universitet) shed light on a significant health concern for patients using Ozempic (semaglutide), a popular medication for managing type 2 diabetes. The studies reveal a more than twofold increased risk of developing Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION), a rare and serious eye condition…

Read More

Subscribe to Our Newsletter